Daiichi Sankyo's R&D expenditure FY 2012-2021

Published by Statista Research Department, Jan 3, 2023
In the fiscal year 2021, Daiichi Sankyo Co., Ltd. spent approximately 260.2 billion Japanese yen on research and development, up from around 227.4 billion Japanese yen in the previous fiscal year.
Main products of the Japanese pharmaceutical company include oncology medications, cardiovascular medications and vaccines.

Annual research and development expenses of Daiichi Sankyo Co., Ltd. in fiscal years 2012 to 2021 (in billion Japanese yen)

Exclusive Premium statistic

You need a Statista Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Statista Accounts
View for free

Access to this and all other statistics on 80,000 topics from

$468 USD / Year
$708 USD / Year

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

November 2022

Region

Japan

Survey time period

fiscal years 2012 to 2021; the company's fiscal year starts on April 1 of the stated year and ends on March 31 of the following year

Supplementary notes

Figures are based on International Financial Reporting Standards (IFRS).
100 Japanese yen equal 0.76 U.S. dollars or 0.71 euros as of January 2023.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " GlaxoSmithKline Pharmaceuticals Limited India "

The most important statistics
The most important statistics
The most important statistics

Statistics on GlaxoSmithKline Pharmaceuticals Limited India

Overview

8

Key figures

6

Major players

5

Further related statistics

12

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in ChinaCoronavirus COVID-19 in ChinaPharmaceutical industry in JapanVaccine industry in ChinaPharmaceuticals in India
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu